Home › Funds › GAGNON SECURITIES LLC › PCRX
GAGNON SECURITIES LLC position in PCRX
PACIRA BIOSCIENCES INC · Health Care
GAGNON SECURITIES LLC reported holding 624,805 shares of PCRX (PACIRA BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$15.7M, representing 2.71% of its reported portfolio and ranking #14 among its reported holdings. GAGNON SECURITIES LLC has disclosed PCRX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How GAGNON SECURITIES LLC's PCRX position evolved
GAGNON SECURITIES LLC first disclosed a stake in PCRX in Q3 2023 at 565,429 shares (US$17.3M). The position peaked in Q4 2023 at 545,579 shares, worth US$18.4M. Across 13 filings, GAGNON SECURITIES LLC increased the stake 8 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 624,805 shares valued at US$15.7M — an increase of 16,188 shares quarter over quarter.. Notable position changes include a 49% trim in Q3 2024 (shares rose 25% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 565.43K | $17.35M | New |
| Q4 2023 | 545.58K | $18.41M | Reduce |
| Q1 2024 | 548.97K | $16.04M | Add |
| Q2 2024 | 596.59K | $17.07M | Add |
| Q3 2024 | 306.94K | $4.62M | Reduce |
| Q4 2024 | 321.74K | $6.06M | Add |
| Q1 2025 | 308.33K | $7.66M | Reduce |
| Q2 2025 | 368.35K | $8.80M | Add |
| Q3 2025 | 449.72K | $11.59M | Add |
| Q4 2025 | 501.21K | $12.97M | Add |
| Q1 2026 | 617.51K | $13.96M | Add |
| Q2 2026 | 608.62K | $15.44M | Reduce |
| Q3 2026 | 624.80K | $15.65M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PCRX and 13F data
PCRX (PACIRA BIOSCIENCES INC) is a Health Care company. 20 other funds we track also report a position in PCRX — the largest reported positions include Context Capital Management, LLC (US$87.0M), Doma Perpetual Capital Management LLC (US$70.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PCRX
- Context Capital Management, LLC 88.81M sh · $87.01M · Q3 2026
- Doma Perpetual Capital Management LLC 2.78M sh · $70.47M · Q2 2026
More on GAGNON SECURITIES LLC
FAQ
How long has GAGNON SECURITIES LLC held PCRX?
GAGNON SECURITIES LLC has disclosed PCRX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is GAGNON SECURITIES LLC's current position in PCRX?
As of Q3 2026, GAGNON SECURITIES LLC holds 624.80K shares of PCRX (PACIRA BIOSCIENCES INC), valued at $15.65M, representing 2.71% of its reported portfolio and ranking #14.
Has GAGNON SECURITIES LLC been buying or selling PCRX?
In the latest 13F filing (Q3 2026), GAGNON SECURITIES LLC increased its position in PCRX. The position peaked in Q4 2023 at 545.58K shares.
Which other funds hold PCRX?
Other major institutional holders of PCRX include Context Capital Management, LLC, Doma Perpetual Capital Management LLC, among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.